NCRI Press Release, 8 November 2010
Test selects 60 per cent of women with inherited ovarian cancer who could benefit from ‘smart’ drug
Download the attachment
Test selects 60 per cent of women with inherited ovarian cancer who could benefit from ‘smart’ drug
Download the attachment
Registration is now open for the 4th NCRI Lung Cancer Trials Meeting on 10 May 2019. Find out about the latest tria… https://t.co/Vv5WeAS0hT
3 days agoA moving tribute to Peter Rainey, who was also a member our Consumer Forum. Very much missed by his friends and col… https://t.co/47lpN7DHMt
3 days agoRT @IainFrame : @matthewreedblog @mariecurieuk Welcome to @mariecurieuk @matthewreedblog . We look forward to working with you @NCRI_partners …
5 days ago